“…The disruption of the epithelial barrier leads to the exposure of the underlying tissues to a multitude of antigens in the intestinal lumen, some of them with pro-inflammatory potential. As the disease progresses, bacterial translocation and inflammatory process are spreading and generalizing, with moderate effects due to the prompt initiation of antiretroviral therapy 12,13 . Indirect evidence of intestinal epithelial barrier disruption, bacterial translocation and inflammatory processes comes from studies which demonstrated an increased plasma concentration of substances associated with these processes, such as lipopolysaccharide (LPS), CD14s (LPS co-receptor), intestinal fatty-acid binding protein (I-FABP) (biomarker of apoptosis in intestinal epithelial cells) and the decrease of others, such as zonulin 14 .…”